Responses
Short report
A pilot study of oral calcitriol (1,25-dihydroxyvitamin D3) for relapsing–remitting multiple sclerosis
Compose a Response to This Article
Other responses
Jump to comment:
- Published on: 13 April 2016
- Published on: 13 April 2016Is there any role of parathyroid hormone in relapsing-remitting multiple sclerosis?Show More
Dear Editor,
Re: Wingerchuk et al:
I have reviewed your study which is a small size study of only 15 patients. Your result showed that disease aggravation was unlikely during study period, but you have not mentioned about duration and type of sun exposure during this period which is very important factor in this study as well as in other studies.
Is there any role of calcitriol during relapse, as you ha...
Conflict of Interest:
None declared.